Reducing G60 Recidivism Rates

March 18, 2026 updated by: Methodist Health System
The research surrounding best practice guidelines of geriatric trauma patients in the inpatient setting is broad. Furthermore, the comprehensiveness of research programs varies based on individual hospital resource capacity. American College of Surgeons Trauma Quality Improvement Program (ACS TQIP) Geriatric Trauma Management Guidelines1 details a comprehensive, multidisciplinary approach to inpatient management; however, guideline effectiveness is diminished as many hospitals may implement a version of the guidelines limited by staffing, ancillary services, and resource capacity, among other variables.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Risk of future falls in elderly patients increases based on multiple factors including increased age and history of previous falls. However, there is limited research showing evidenced-based interventions that reduce recidivism rates related to falls. The Centers for Disease Control and Prevention (CDC) has an evidenced-based fall prevention program (Stopping Elderly Accidents, Deaths & Injuries [STEADI3]). Implementation of STEADI as part of a multidisciplinary approach to fall risk assessment and prevention prior to discharge may reduce recidivism in elderly patients.

Ground level falls are the most common mechanism of injury in older adults and are increasingly becoming a significant cause of morbidity and mortality in this population. An individual's risk of a repeat ground level fall increases after an initial fall, injury, or hospitalization7. Addressing fall risk factors and tailoring inpatient care for any trauma in the elderly population prior to discharge will likely improve outcomes, decrease length of stay, and decrease morbidity and mortality.

The introduction of STEADI as part of a specialized multidisciplinary approach to fall risk assessment and prevention prior to hospital discharge may reduce recidivism in elderly patients. Patients that attend the discharge class are typically more likely to go home and return to independence whereas those that do not attend the discharge class are likely to have a disposition of going to a long-term care facility or are not mentally capable of retaining information. Reduced falls as a result of STEADI implementation will putatively improve mortality rates and quality of life in elderly patients.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75203
        • Methodist Dallas Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

G60 patients across all MHS hospitals between 2019 and 2022

Description

Inclusion Criteria:

  • 60 years or older
  • G60 activation and admission
  • Primary admission for injury

Exclusion Criteria:

  • Less than 60 years old
  • Admitted for non-traumatic injuries
  • Non-index admission for injury
  • Prisoners
  • Pregnant or lactating subjects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Geriatric patients that attended fall prevention discharge class
recidivism rates of MDMC-qualified G60 patients that attended fall prevention discharge class per hospital protocols
Participants attend fall prevention discharge class per hospital protocols
Geriatric patients that did not attend fall prevention discharge class
recidivism rates of MDMC-qualified G60 patients that did not attended fall prevention discharge class per hospital protocols

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with repeat Emergency Department(ED) visits with a chief complaint associated with a fall.
Time Frame: 2019-2022
review of G60 patients across all MHS hospitals after system standard order set initiation and utilization as the comparative group for a 2-year period.
2019-2022
• Number of return visits related to a fall treated at a Methodist Health System(MHS)trauma center before and after implementation of G60 targeted education.
Time Frame: 2019-2022
• Observational study comparing recidivism rates of MDMC-qualified G60 patients that attended fall prevention discharge class per hospital protocols versus G60 patients that did not attend the class
2019-2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sarah Bradley, RN, Methodist Health System

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 18, 2021

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2028

Study Registration Dates

First Submitted

February 3, 2022

First Submitted That Met QC Criteria

February 3, 2022

First Posted (Actual)

February 4, 2022

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 036.TRA.2021.A

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fall Injury

Clinical Trials on Fall prevention class

Subscribe